{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-22-000257","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2022-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.662879+00:00","generated_at":"2026-06-21T05:18:12.974910+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Tandem Diabetes Care to acquire AMF Medical (Sigi Patch Pump) for up to CHF 200M","bullets":["Cash payment of CHF 62.4M at closing plus CHF 8M prior strategic investment; earnouts up to CHF 129.6M.","Earnouts: CHF 38.4M upon key development milestones over next two years; CHF 91.2M upon FDA clearance of ACE pump.","Transaction expected to close January 2023, subject to no material adverse effect and other customary conditions.","Acquires Sigi Patch Pump technology, expanding insulin delivery pipeline for Tandem."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-22-000257","json":"https://secwatch.observer/filing/0001438133-22-000257.json","markdown":"https://secwatch.observer/filing/0001438133-22-000257.md","text":"https://secwatch.observer/filing/0001438133-22-000257.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000257/0001438133-22-000257-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000257/tndm-20221210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T05:18:12.974910+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5906e3571edd329239ad4e16bcf74df3b4e6a06c","claim":"TANDEM DIABETES CARE INC entered into Share Purchase Agreement with the Sellers listed on Annex B attached thereto and AMF Medical SA valued at CHF 62.4 million (effective 2022-12-10).","evidence_excerpt":"On December 10, 2022 , Tandem Diabetes Care, Inc., a Delaware corporation (the “Company”), entered into a Share Purchase Agreement (the “Purchase Agreement”) with the Sellers listed on Annex B attached thereto (collectively, the “Sellers” and each, individually, a “Seller”) and AMF Medical SA, a corporation organized and existing under the laws of Switzerland (“AMF Medical”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000257/0001438133-22-000257-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"the Sellers listed on Annex B attached thereto and AMF Medical SA"},{"label":"Value","value":"CHF 62.4 million"},{"label":"Effective","value":"2022-12-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}